None listed
Conditions
Sponsors
Samsung Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: -Adults who undergo elective hepatectomy for hepatocellular carcinoma (older than 18 years old and younger than 76 years old) -American society of anesthesia (ASA) class I-III -Patients who have agreed to the trial and signed the subject's consent
Exclusion criteria
Exclusion criteria: - Patients with who have history of side effects from the use of the anesthetic or have contraindication for drugs (a patient suspected of having an allergic reaction to the drug) - Patients who have liver cancer other than hepatocellular carcinoma (eg Cholangiocarcinoma or metastatic liver tumor) - Patients who is deemed inappropriate to participate in the clinical trial by the researcher's judgment - Patients who are allergic to nuts or beans - Patients who have a history of malignant hyperthermia or risk factors of malignant hyperthermia - Patients who underwent interventional procedure for HCC - Patients who have elevated intracranial hypertension - Patients who have distant metastasis to other organ - Patients who undergo ALPS (Associating liver partition and portal vein ligation for staged hepatectomy)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1 year recurrence free survival | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 year overall recurrence;1 year overall metastasis;1 year overall survival;3 year recurrence free survival;3 year overall survival;3 year recurrence;3 year metastasis | — |
Countries
Korea, Republic of
Contacts
Public ContactJi-Hye Kwon
Samsung Medical Center
Outcome results
None listed